MedPath

Comparison between Clonidine and Lignocaine in response to laryngoscopy and endotracheal intubation

Not yet recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2021/10/037063
Lead Sponsor
Dr Shahbaz Haroon
Brief Summary

It is a randomized, prospective, comparative, double blinded, observational study where in intravenous lignocaine and intravenous clonidine are compared for the attenuation of hemodynamic pressor responses during laryngoscopy and endotracheal intubation before any surgical procedures in the operation theatre.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Age between 18-60 yr of either sex.
  • ASA grade I and grade II.
  • Patients posted for elective surgeries under general anesthesia requiring intubation.
  • Hemodynamically stable patients having all routine investigations within normal limits.
  • Patients who give written informed consent and are willing to be part of the study.
Exclusion Criteria
  • Patients refusal.
  • Patients with ASA physical status III and more.
  • Patients with any pre-existing cardiovascular disease.
  • Patients with h/o allergy to test drugs.
  • Patients posted for emergency surgeries.
  • Patients with difficult airway.
  • Patients with neurological disorders and muscle diseases.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To observe the attenuation of pressor responses to laryngoscopy and endotracheal intubation with intravenous clonidinePRE INTUBATION, SCOPY 0 MINS, EVERY 5 MINUTES, UPTO 2 HOURS INTRA-OP, POST OP VAS, SEDATION
Secondary Outcome Measures
NameTimeMethod
To study the side effects of Clonidine and Lignocaine, if any and Ramsay sedation scaleRamsay sedation scale: immediately, 1 hour, 6 hour and 12 hour after surgery

Trial Locations

Locations (1)

Hightech OT complex, 5th floor, Hightech building

🇮🇳

Pune, MAHARASHTRA, India

Hightech OT complex, 5th floor, Hightech building
🇮🇳Pune, MAHARASHTRA, India
Dr Shahbaz Haroon
Principal investigator
8105236310
shahbaz.haroon92@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.